(Q51419809)

5 April 2018

title

Screening postmortem blood and tissues for nine classes [correction of cases] of drugs of abuse using automated microplate immunoassay. (English)

1 reference

5 April 2018

0 references

Moore KA

1

1 reference

5 April 2018

Werner C

2

1 reference

5 April 2018

Zannelli RM

3

1 reference

5 April 2018

Levine B

4

1 reference

5 April 2018

Smith ML

5

1 reference

5 April 2018

publication date

1 December 1999

1 reference

5 April 2018

Forensic Science International

published in

1 reference

5 April 2018

volume

106

1 reference

5 April 2018

issue

2

1 reference

5 April 2018

page(s)

93-102

1 reference

5 April 2018

Screening of blood and urine for drugs of abuse utilizing diagnostic products corporation's Coat-A-Count radioimmunoassay kits.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900182-6

7 January 2021

Radioimmunoassay screening and GC/MS confirmation of whole blood samples for drugs of abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900182-6

7 January 2021

Application of the Abbott TDx lidocaine, phenytoin, and phenobarbital assays to postmortem blood specimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900182-6

7 January 2021

Direct detection of drugs of abuse in whole hemolyzed blood using the EMIT d.a.u. urine assays.

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900182-6

7 January 2021

A novel procedure for the analysis of drugs in whole blood by homogeneous enzyme immunoassay (EMIT).

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900182-6

7 January 2021

Modification of Emit Assay Reagents for Improved Sensitivity and Cost Effectiveness in the Analysis of Hemolyzed Whole Blood

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900182-6

7 January 2021

Validation of an automated microplate enzyme immunoassay for screening of postmortem blood for drugs of abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900182-6

7 January 2021

alpha-Benzyl-N-methylphenethylamine (BNMPA), an impurity of illicit methamphetamine synthesis: I. Physical characterization and GC-MS analysis of BNMPA and anticipated metabolites in urine

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900182-6

7 January 2021

Determination of temazepam and temazepam glucuronide by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900182-6

7 January 2021

Simultaneous determination of cocaine and benzoylecgonine in urine by gas-liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900182-6

7 January 2021

Determination of lysergic acid diethylamide (LSD), iso-LSD, and N-demethyl-LSD in body fluids by gas chromatography/tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900182-6

7 January 2021

Screening for drugs in forensic blood samples using EMIT urine assays.

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900182-6

7 January 2021

Direct automated EMIT d.a.u. analysis of N,N-dimethylformamide-modified serum, plasma, and postmortem blood for amphetamines, barbiturates, methadone, methaqualone, phencyclidine, and propoxyphene

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900182-6

7 January 2021

10.1016/S0379-0738(99)00182-6

Identifiers

DOI

1 reference

5 April 2018

PubMed ID

10664895

1 reference

5 April 2018